Compound information
- Natural Products
- ZC1185758
- Molecular Formula
- C16H20O5
- Molecular Weight
- 292.13107374 g/mol
- Structure
-
- IUPAC Name
- (3,3-dimethyl-2-oxo-butyl) (E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoate
- InChI
- InChI=1S/C16H20O5/c1-16(2,3)14(18)10-21-15(19)8-6-11-5-7-12(17)13(9-11)20-4/h5-9,17H,10H2,1-4H3/b8-6+
- InChI Key
- HODLCQJLRMUGLI-SOFGYWHQSA-N
- SMILES
- COc1cc(/C=C/C(=O)OCC(=O)C(C)(C)C)ccc1O
- Source
- ZINC000003342181
Warheads
- Carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 21 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 72.83 Å2 | LogP | 2.591 |
LogS | -4.039 | LogD | 2.769 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.134 | Pgp substrate | 0.208 |
HIA | 0.961 | F20 % | 0.992 |
F30 % | 0.902 | Caco-2 | -4.812 |
MDCK | -4.867 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.441 | PPB | 87.183 |
VD | 0.861 | Fu | 0.542 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.996 | CYP1A2 substrate | 0.44 |
CYP2A6 substrate | 0.679 | CYP2B6 substrate | 0.656 |
CYP2C19 inhibitor | 0.205 | CYP2C19 substrate | 0.626 |
CYP2C8 substrate | 0.651 | CYP2C9 inhibitor | 0.46 |
CYP2C9 substrate | 0.981 | CYP2D6 inhibitor | 0.201 |
CYP2D6 substrate | 0.28 | CYP2E1 substrate | 0.38 |
CYP3A4 inhibitor | 0.039 | CYP3A4 substrate | 0.484 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.977 | CL | 13.811 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.003 | Hepatotoxicity | 0.898 |
Mutagenicity | 0.004 | Rat Oral Acute Toxicity | 0.024 |
FDAMDD | 0.697 | Skin Sensitization | 0.997 |
Carcinogenicity | 0.27 | Eye Corrosion | 0.018 |
Eye Irritation | 0.907 | Respiratory Toxicity | 0.501 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.075 | IGC50 | 4.248 |
LC50FM | 5.425 | LC50DM | 6.331 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.302 | NR-AR-LBD | 0.597 |
NR-AhR | 0.214 | NR-Aromatase | 0.131 |
NR-ER | 0.898 | NR-ER-LBD | 0.762 |
NR-PPAR-gamma | 0.919 | SR-ARE | 0.689 |
SR-ATAD5 | 0.822 | SR-HSE | 0.811 |
SR-MMP | 0.893 | SR-p53 | 0.757 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.